elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47842086-5B718B41-053E-4486-8A0D-159F62DB0DA6
Q47842086-5B718B41-053E-4486-8A0D-159F62DB0DA6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47842086-5B718B41-053E-4486-8A0D-159F62DB0DA6
Toward inclusive therapy with CFTR modulators: Progress and challenges.
P2860
Q47842086-5B718B41-053E-4486-8A0D-159F62DB0DA6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47842086-5B718B41-053E-4486-8A0D-159F62DB0DA6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ce92d2afc93202308c3959c1f11ac6a83cf161f9
P2860
Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging Pharmacotherapies.